Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Express Scripts Will Stick With Medicare Cards, Despite Slow Uptake

Executive Summary

Express Scripts plans to continue its partnership with the National Association of Chain Drug Stores on Medicare-endorsed discount cards into 2005 and beyond, the pharmacy benefit management company said July 29

You may also be interested in...



Medicare Rx Card: All Sponsors Return For 2005 Run-Up To Part D Benefit

All of the companies sponsoring a Medicare prescription drug discount card in 2004 will offer cards again in 2005

Medicare Rx Card: All Sponsors Return For 2005 Run-Up To Part D Benefit

All of the companies sponsoring a Medicare prescription drug discount card in 2004 will offer cards again in 2005

Medicare Discount Card Used For 3% Of Senior Rxs As Outreach Increases

The number of prescriptions filled using Medicare drug discount cards has reached 3% of all those filled by people age 65 and over, IMS Health VP-Industry Relations Doug Long said

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS044422

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel